Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Dendreon Corporation    

SynthèseActualitésAgendaSociétéFinancesFondsCommunauté 
Métier
Discovers, develops and commercializes novel products for the treatment of cancer

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer.

The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types.

It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.

Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Dirigeants
Nom AgeDepuisTitre
Craig R. Jalbert552015President, Secretary, Treasurer & Director
William Monteith582009Executive Vice President-Technical Operations
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 158 716 893 153 327 147 96.6% 0 0.0% 96.6%
Secteur Recherche biotechnologique et médicale - NCA
Connexions : Dendreon Corporation
Coordonnées société
Dendreon Corp.
1208 Eastlake Avenue East
Seattle, WA 98102

Phone : +1.206.256.4545
Fax : +1.206.256.0571
Web : www.dendreon.com
© 2017 People , Fundamentals and Ownership